Erlotinib

Erlotinib


Erlotinib (CP-358774) is a potent EGFR tyrosine kinase inhibitor with an IC50 of 2 nM for human EGFR and 20 nM for EGFR autophosphorylation in tumor cells. It is used to treat non-small cell lung cancer and also functions as a click chemistry reagent, containing an alkyne group for copper-catalyzed azide-alkyne cycloaddition (CuAAC). Reagent grade, for research use only.

Molecular structure of the compound BP-43654
    • Unit
    • Price
    • Qty
    • 10 G
    • $150.00
    • 25 G
    • $280.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire